Send to

Choose Destination
See comment in PubMed Commons below
Int Clin Psychopharmacol. 2014 Jul;29(4):235-8. doi: 10.1097/YIC.0000000000000027.

The use of psychiatric drugs and worsening body mass index among inpatients with schizophrenia.

Author information

aDepartment of Psychiatry, Tsao-Tun Psychiatric Center, Department of Health, Executive Yuan, Nantou County bTaiwan Research Association of Health Care, Taichung, Taiwan.


The aim of the present study was to investigate the relationship between 10 psychotropic agents and worsening BMI from overweight to obesity among inpatients with schizophrenia. A total of 138 patients with schizophrenia were recruited in this retrospective study. We included 23 patients with worsening BMI, from overweight (24≤BMI<27 kg/m²) to obesity (BMI≥27 kg/m²), as the case group and 115 patients without a worse BMI as the control group. Data were analyzed to assess the relationships between psychiatric drug use and BMI that worsened from overweight to obesity. Of the 138 patients, 60.9% were men. Their mean age was 47.2±9.7 years, mean age of onset of disease was 32.2±10.4 years, and the mean length of illness 15.0±6.5 years. Valproic acid was found to have a significant impact on the worsening of BMI from overweight to obesity (P<0.05). Age at onset of disease, length of illness, and duration of hospitalization were not associated significantly with worsening of BMI from overweight to obesity. These results call for caution in using valproic acid in schizophrenic inpatients with BMIs indicating overweight or obesity.

[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Support Center